GSK-3β is thought to be a key player in AD since its dysregulation is associated with several significant hallmarks of the disease, including tau hyperphosphorylation, Aβ accumulation, synaptic dysfunction, and microglia-mediated neuroinflammation (Lauretti et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.